Not Found
Digital Seminar

Pharmacology of Infectious Disease: Essential Elements for an Impactful Clinical Pharmacy Practice


Faculty:
Eric Wombwell, PharmD, BCIDP
Duration:
6 Hours 28 Minutes
Format:
Audio and Video
Copyright:
Feb 15, 2021
Product Code:
POS078180
Media Type:
Digital Seminar - Also available: DVD


Description

Dr. Eric Wombwell, PharmD, and Board Certified Infectious Disease Pharmacist will be your guide in this seminar, as you learn the latest evidence in the pharmacology of infectious diseases and application of this evidence to enhance your clinical pharmacy practice. 

With new antibiotics, vaccines, treatment guidelines, and evidence-based research continuously becoming available, the need to stay up-to-date is an imperative for pharmacists.  The CDC recommends that pharmacists receive ongoing education about a variety of areas, including adverse reactions to antibiotics, antibiotic resistance and optimal prescribing.

Dr. Wombwell will draw attention to clinical situations where antibiotics are overprescribed, unnecessarily used, and underutilized in the treatment of infections. He will provide approaches to improve antibiotic use in these situations—resulting in reduced antibiotic cost, resistance, and collateral damage, improving patient outcomes in both outpatient and inpatient environments.

You’ll leave with the knowledge and strategies to:  

  • Integrate current, best-practice treatment guidelines
  • Limit adverse reactions from antibiotics
  • Implement antimicrobial de-escalation strategies
  • And more!

The need for robust antibiotic stewardship has never been more pressing.  Purchase today!

 

Credits


**

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after completing and passing the on-line post-test evaluation). 

Continuing Education Information:  Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, please contact cepesi@pesi.com or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.  

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.


Pharmacists

ACPE

Successful completion of this Application-based self-study program qualifies for 6.3 self-study contact hours. PESI, Inc. is on probation as an accredited provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education. Next scheduled review: June 2021. ACPE Universal Program Number: 0289-0000-21-004-H01-P. This activity was originally released on 03/05/2021 and is valid until 03/05/2024. No partial contact hours will be awarded for partial attendance. Please note: Pharmacists are required to view the program in its entirety, complete a program evaluation and achieve a passing score of 80% or higher on a post-test in order to have their participation submitted to ACPE. A valid NABP e-Profile ID and Birthdate (MM/DD) will be required for reporting. Don’t have your e-Profile ID yet? Visit the National Association of Boards of Pharmacy (NABP) website and complete your e-profile at https://nabp.pharmacy/ in order to obtain your NABP e-Profile ID.



Handouts/Brochure

Faculty

Eric Wombwell, PharmD, BCIDP's Profile

Eric Wombwell, PharmD, BCIDP Related seminars and products


Eric Wombwell, PharmD, BCIDP, is a board-certified infectious diseases pharmacist and Clinical Associate Professor for the Department of Pharmacy Practice and Administration at the University of Missouri - Kansas City, School of Pharmacy.

Dr. Wombwell completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center. Upon residency completion, Wombwell accepted a full-time non-tenured clinical faculty position at the Kansas City VA Medical Center. Upon residency completion, Wombwell accepted a full-time non-tenured clinical faculty position at the University of Missouri - Kansas City, School of Pharmacy. His responsibilities include teaching Doctor of Pharmacy students in a variety of courses with special emphasis in the area of infectious diseases. As part of this position, Wombwell serves as a Clinical Pharmacy Specialist, working as part of the multidisciplinary team, providing care to acutely ill patients at Centerpoint Medical Center in Independence, Missouri.

Dr. Wombwell is well-published in pharmacy and infectious diseases-related topics and is frequently invited to present on infectious diseases topics locally and nationally to various health-professional audiences. He has been named teacher-of-the year in various capacities over 10-times, including the "UMKC Provost's Award for Excellence in Teaching."

Speaker Disclosures:

Financial: Eric Wombwell is a Clinical Assistant Professor, Department of Pharmacy Practice at the University of Missouri – Kansas City. He receives a speaking honorarium from PESI, Inc.
Non-financial: Eric Wombwell has no relevant nonfinancial relationships to disclose.


Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Objectives

  1. Develop antibiotic recommendations in response to microbiologic testing results.
  2. Describe clinical scenarios compelling for empiric coverage of resistant bacteria.
  3. Discriminate clinical scenarios requiring initiation of antibiotics.
  4. Choose appropriate risk factor–based empiric antibiotic regimens for acute infections.
  5. Recognize clinical scenarios necessitating avoidance of specific antibiotics based on side effect profiles.
  6. Identify clinical situations appropriate for newly approved antimicrobials.

Outline

Considerations for Successful Empiric Therapy

  • Spectrum of activity for commonly used antibiotics
  • Normal flora for infectious sites
  • Resistance associated with common bacteria
  • Pharmacodynamic influences on antibiotic dosing

Interpretation of Microbiologic Test Results 

  • Gram stain results
  • Culture and sensitivity results
  • Minimum inhibitory concentration (MIC) evaluation
  • PCR results

Antibacterial Resistance

  • Trends
  • Mechanisms of resistance
  • Contributing factors
  • Antibiotic stewardship concepts

Antibiotic Related Allergies– Penicillin and ‘Sulfa’

  • Define true allergy versus side effect
  • Penicillin allergy and cephalosporin cross sensitivity 
  • ‘Sulfa’ allergy

SARS-CoV-2

  • Clinical trial data for therapeutics
  • Clinical trial data for vaccines

Skin and Soft Tissue Infections

  • Streptococcus pyogenes vs. MRSA
  • Evidence for antibiotic management
  • IDSA treatment guidelines
  • Vancomycin AUC/MIC monitoring

Pneumonia

  • Evidence for pathogen etiology
  • Evidence for antibiotic management
  • IDSA/ATS community-acquired pneumonia treatment guidelines
  • Resistance risk factors and management
  • IDSA/ATS hospital- and ventilator-acquired pneumonia treatment guidelines
  • New antibiotics for MDR infections

Influenza

  • Evidence on vaccine timing and use in older adults
  • Clinical trial data for therapeutics
  • IDSA/CDC treatment guidelines

Urinary Tract Infections

  • Resistance trends
  • Clinical trial data for therapeutics
  • Antibiotics for MDR infections

Clostridium Difficile Infection

  • Risk factor literature review
  • Compare antibiotic risk levels
  • IDSA treatment guidelines
  • Clinical trial data for therapeutics
  • Probiotics prophylaxis evidence review
     

Target Audience

Inpatient and outpatient pharmacists engaged in review of antimicrobial prescription orders. In particular, those pharmacists interested in obtaining further antimicrobial expertise to aid in the care of patients with infectious diseases through optimal antimicrobial drug choice, route, dose, and duration of use.

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

PESI Mobile App

Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of live webcasts and online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.

https://ce21.blob.core.windows.net/images/android.png     https://ce21.blob.core.windows.net/images/iphone.png

Please wait ...

Back to Top